108 related articles for article (PubMed ID: 16157217)
1. TRAIL and docosahexaenoic acid cooperate to induce HT-29 colon cancer cell death.
Vaculová A; Hofmanová J; Andera L; Kozubík A
Cancer Lett; 2005 Nov; 229(1):43-8. PubMed ID: 16157217
[TBL] [Abstract][Full Text] [Related]
2. Ethanol acts as a potent agent sensitizing colon cancer cells to the TRAIL-induced apoptosis.
Vaculová A; Hofmanová J; Soucek K; Andera L; Kozubík A
FEBS Lett; 2004 Nov; 577(1-2):309-13. PubMed ID: 15527805
[TBL] [Abstract][Full Text] [Related]
3. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
4. 17-Allylamino-17-demethoxygeldanamycin overcomes TRAIL resistance in colon cancer cell lines.
Vasilevskaya IA; O'Dwyer PJ
Biochem Pharmacol; 2005 Aug; 70(4):580-9. PubMed ID: 15993848
[TBL] [Abstract][Full Text] [Related]
5. [Action of apoptosis-induced ligand gene in relation to tumor necrosis factor on human colon cancer cell line HT29].
He C; Hu X; Xu X; Fang B
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):133-6. PubMed ID: 12015033
[TBL] [Abstract][Full Text] [Related]
6. Global effects of anchorage on gene expression during mammary carcinoma cell growth reveal role of tumor necrosis factor-related apoptosis-inducing ligand in anoikis.
Goldberg GS; Jin Z; Ichikawa H; Naito A; Ohki M; El-Deiry WS; Tsuda H
Cancer Res; 2001 Feb; 61(4):1334-7. PubMed ID: 11245430
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
[TBL] [Abstract][Full Text] [Related]
8. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
Frese S; Frese-Schaper M; Andres AC; Miescher D; Zumkehr B; Schmid RA
Cancer Res; 2006 Jun; 66(11):5867-74. PubMed ID: 16740726
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
[TBL] [Abstract][Full Text] [Related]
10. Response of normal and colon cancer epithelial cells to TNF-family apoptotic inducers.
Hofmanová J; Vaculová A; Hyzd'alová M; Kozubík A
Oncol Rep; 2008 Feb; 19(2):567-73. PubMed ID: 18202809
[TBL] [Abstract][Full Text] [Related]
11. Halocynthiaxanthin and peridinin sensitize colon cancer cell lines to tumor necrosis factor-related apoptosis-inducing ligand.
Yoshida T; Maoka T; Das SK; Kanazawa K; Horinaka M; Wakada M; Satomi Y; Nishino H; Sakai T
Mol Cancer Res; 2007 Jun; 5(6):615-25. PubMed ID: 17579120
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
13. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.
Shankar S; Singh TR; Fandy TE; Luetrakul T; Ross DD; Srivastava RK
Int J Mol Med; 2005 Dec; 16(6):1125-38. PubMed ID: 16273296
[TBL] [Abstract][Full Text] [Related]
14. Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage.
Jin CY; Park C; Moon SK; Kim GY; Kwon TK; Lee SJ; Kim WJ; Choi YH
Anticancer Drugs; 2009 Sep; 20(8):713-22. PubMed ID: 19617819
[TBL] [Abstract][Full Text] [Related]
15. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway.
Wang X; Ju W; Renouard J; Aden J; Belinsky SA; Lin Y
Cancer Res; 2006 Jan; 66(2):1089-95. PubMed ID: 16424045
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae.
Martin S; Phillips DC; Szekely-Szucs K; Elghazi L; Desmots F; Houghton JA
Cancer Res; 2005 Dec; 65(24):11447-58. PubMed ID: 16357153
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture.
Di Pietro R; Mariggiò MA; Guarnieri S; Sancilio S; Giardinelli A; Di Silvestre S; Consoli A; Zauli G; Pandolfi A
J Cell Biochem; 2006 Mar; 97(4):782-94. PubMed ID: 16229016
[TBL] [Abstract][Full Text] [Related]
18. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
[TBL] [Abstract][Full Text] [Related]
19. Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function.
Li Y; Wang H; Wang Z; Makhija S; Buchsbaum D; LoBuglio A; Kimberly R; Zhou T
Cancer Res; 2006 Sep; 66(17):8520-8. PubMed ID: 16951164
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]